[HTML][HTML] A current view on Tau protein phosphorylation in Alzheimer's disease

S Wegmann, J Biernat, E Mandelkow - Current opinion in neurobiology, 2021 - Elsevier
The functions of the neuronal microtubule-associated protein Tau in the central nervous
system are regulated by manifold posttranslational modifications at more than 50 sites. Tau …

Tau-targeting therapies for Alzheimer disease: current status and future directions

EE Congdon, C Ji, AM Tetlow, Y Jiang… - Nature Reviews …, 2023 - nature.com
Alzheimer disease (AD) is the most common cause of dementia in older individuals. AD is
characterized pathologically by amyloid-β (Aβ) plaques and tau neurofibrillary tangles in the …

[HTML][HTML] Tau PTM profiles identify patient heterogeneity and stages of Alzheimer's disease

H Wesseling, W Mair, M Kumar, CN Schlaffner, S Tang… - Cell, 2020 - cell.com
To elucidate the role of Tau isoforms and post-translational modification (PTM) stoichiometry
in Alzheimer's disease (AD), we generated a high-resolution quantitative proteomics map of …

Tau post-translational modifications: dynamic transformers of tau function, degradation, and aggregation

C Alquezar, S Arya, AW Kao - Frontiers in neurology, 2021 - frontiersin.org
Post-translational modifications (PTMs) on tau have long been recognized as affecting
protein function and contributing to neurodegeneration. The explosion of information on …

Tau: Enabler of diverse brain disorders and target of rapidly evolving therapeutic strategies

CW Chang, E Shao, L Mucke - Science, 2021 - science.org
BACKGROUND The microtubule-associated protein tau has been implicated in the
pathogenesis of Alzheimer's disease and a range of other neurodegenerative disorders …

Tau protein liquid–liquid phase separation can initiate tau aggregation

S Wegmann, B Eftekharzadeh, K Tepper… - The EMBO …, 2018 - embopress.org
The transition between soluble intrinsically disordered tau protein and aggregated tau in
neurofibrillary tangles in Alzheimer's disease is unknown. Here, we propose that soluble tau …

Tau kinetics in neurons and the human central nervous system

C Sato, NR Barthélemy, KG Mawuenyega… - Neuron, 2018 - cell.com
We developed stable isotope labeling and mass spectrometry approaches to measure the
kinetics of multiple isoforms and fragments of tau in the human central nervous system …

Tau protein disrupts nucleocytoplasmic transport in Alzheimer's disease

B Eftekharzadeh, JG Daigle, LE Kapinos, A Coyne… - Neuron, 2018 - cell.com
Tau is the major constituent of neurofibrillary tangles in Alzheimer's disease (AD), but the
mechanism underlying tau-associated neural damage remains unclear. Here, we show that …

Amyloid-β and tau complexity—towards improved biomarkers and targeted therapies

JC Polanco, C Li, LG Bodea… - Nature Reviews …, 2018 - nature.com
Most neurodegenerative diseases are proteinopathies, which are characterized by the
aggregation of misfolded proteins. Although many proteins have an intrinsic propensity to …

Tau liquid–liquid phase separation in neurodegenerative diseases

S Boyko, WK Surewicz - Trends in cell biology, 2022 - cell.com
Aggregation of the microtubule-associated protein tau plays a major role in Alzheimer's
disease and several other neurodegenerative disorders. An exciting recent development is …